Deferred Tax Assets, Valuation Allowance of PURE BIOSCIENCE, INC. from 31 Jul 2011 to 31 Jul 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: PURE BIOSCIENCE, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Jul 2011 to 31 Jul 2025.
PURE BIOSCIENCE, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Jul 2025 was $29,290,000, a 0.1% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PURE BIOSCIENCE, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$29,290,000	-$30,000	-0.1%	31 Jul 2025	10-K	29 Oct 2025	2025	FY
Q2 2024	$29,320,000	-$1,010,000	-3.3%	31 Jul 2024	10-K	29 Oct 2025	2025	FY
Q2 2023	$30,330,000	+$820,000	+2.8%	31 Jul 2023	10-K	29 Oct 2024	2024	FY
Q2 2022	$29,510,000	+$670,000	+2.3%	31 Jul 2022	10-K	30 Oct 2023	2023	FY
Q2 2021	$28,840,000	+$470,000	+1.7%	31 Jul 2021	10-K	28 Oct 2022	2022	FY
Q2 2020	$28,370,000	-$470,000	-1.6%	31 Jul 2020	10-K	28 Oct 2021	2021	FY
Q2 2019	$28,840,000	+$210,000	+0.73%	31 Jul 2019	10-K	08 Oct 2020	2020	FY
Q2 2018	$28,630,000	-$5,450,000	-16%	31 Jul 2018	10-K	30 Oct 2019	2019	FY
Q2 2017	$34,080,000	+$67,350,000		31 Jul 2017	10-K	25 Oct 2018	2018	FY
Q2 2016	$33,270,000	-$64,115,000	-208%	31 Jul 2016	10-K	26 Oct 2017	2017	FY
Q2 2015	$30,845,000	+$3,075,000	+11%	31 Jul 2015	10-K	27 Oct 2016	2016	FY
Q2 2014	$27,770,000	+$3,121,000	+13%	31 Jul 2014	10-K	28 Oct 2015	2015	FY
Q2 2013	$24,649,000	+$2,089,000	+9.3%	31 Jul 2013	10-K	28 Oct 2014	2014	FY
Q2 2012	$22,560,000	+$2,657,000	+13%	31 Jul 2012	10-K	24 Oct 2013	2013	FY
Q2 2011	$19,903,000			31 Jul 2011	10-K	29 Oct 2012	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.